Bladder Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Gastrointestinal Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous gastrointestinal cancer clinical trials.

Learn more about participating in a clinical trial at Norton Healthcare.

Active gastrointestinal cancer clinical trials include:

Biliary Tract Cancer

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer

Cholangiocarcinoma

A Phase 3, Open-Label, Randomized Study of Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients with Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements (FOENIX-CCA3)

Colorectal Cancer

Phase II study for the treatment of HER2- positive locally advanced unresectable or metastatic colorectal cancer subjects (CRC)

Colorectal Cancer

A Global, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care to Placebo Plus Best Supportive Care in Patients with Refractory Metastatic Colorectal Cancer (FRESCO-2)

Esophageal Cancer

A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center International Study of Durvalumab Given Concurrently with Definitive Chemoradiation Therapy in Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma

Gastric Cancer

A randomized, double-blind, placebo-controlled, active comparator Phase 2/3 study of tucatinib in combination with trastuzumab, ramucirumab, and paclitaxel in subjects with previously treated, locally-advanced unresectable or metastatic HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC)

Gastric Cancer

A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of IMAB362 Plus mFOLFOX6 Compared with Placebo Plus mFOLFOX6 as First-line Treatment of Subjects with Claudin (CLDN)18.2-Posit

Gastric Cancer

A Randomized, Double-blind, Placebo-controlled, Phase III Study of Neoadjuvant/Adjuvant Durvalumab and Standard Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable Gastric and astroesophageal Cancer (GC/GEJC)

Pancreatic Cancer

A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced, Unresectable Pancreatic Cancer

Six years after his glioblastoma diagnosis, a brain cancer survivor and his wife look back

John and Jessica Bostock were in the middle of exciting life changes as the summer of 2015 started warming up. John was just 35, and the couple had an 18-month-old daughter, Olive. Plans were underway […]

Read Full Story

Three-time cancer survivor encourages others

Bruce Lowe does not take being a cancer survivor for granted. Indeed, surviving three different cancers has given him a mission. “My doctor told me that I had stage 4 incurable bone cancer and had […]

Read Full Story

The latest in noninvasive brain tumor treatment

TrueBeam, CyberKnife and Gamma Knife may sound like superheroes, but actually they are tools for treating brain tumors. These three machines are used for stereotactic radiosurgery (SRS), a non-surgical treatment option that uses high doses […]

Read Full Story

Celebrating cancer survivors and giving them a care plan for a long life

June 6 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

How to talk to your doctor about sex and cancer

Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is […]

Read Full Story
Related Stories

Six years after his glioblastoma diagnosis, a brain cancer survivor and his wife look back

John and Jessica Bostock were in the middle of exciting life changes as the summer of 2015 started warming up. John was just 35, and the couple had an 18-month-old daughter, Olive. Plans were underway […]

Read Full Story

Three-time cancer survivor encourages others

Bruce Lowe does not take being a cancer survivor for granted. Indeed, surviving three different cancers has given him a mission. “My doctor told me that I had stage 4 incurable bone cancer and had […]

Read Full Story

The latest in noninvasive brain tumor treatment

TrueBeam, CyberKnife and Gamma Knife may sound like superheroes, but actually they are tools for treating brain tumors. These three machines are used for stereotactic radiosurgery (SRS), a non-surgical treatment option that uses high doses […]

Read Full Story

Celebrating cancer survivors and giving them a care plan for a long life

June 6 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

How to talk to your doctor about sex and cancer

Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.